Watts, Karina
Garay, Osvaldo Ulises
Ferrante di Ruffano, Lavinia
Kittel, Phillip
Gregg, Emily
Heller, Vincent
Watkins, Deborah
Allen, A. Joy
Shinkins, Bethany
Mallet, Sue
Mealing, Stuart
Holmes, Hayden
Funding for this research was provided by:
Roche Diagnostics International
Article History
Received: 25 November 2025
Revised: 23 February 2026
Accepted: 29 March 2026
First Online: 10 April 2026
Declarations
:
: L. Ferrante di Ruffano, E. Gregg, K. Watts, D. Watkins, S. Mealing and H. Holmes are employees of York Health Economics Consortium (YHEC). YHEC received consultancy fees from Roche Diagnostics International. O.U. Garay, P. Kittel and V. Heller are employees of Roche Diagnostics International and own shares in Roche. (A) J. Allen is an employee of Roche Diagnostics Limited and owns shares in Roche. S. Mallet and (B) Shinkins declare no conflicts of interest.
: No ethical approval was required for this research.
: Written informed consent to participate was obtained from the interviewees.
: Written informed consent to publish was obtained from the interviewees.